source
- STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more newsTwo drugmakers asked the U.S. Supreme Court to restore mail-order access to the abortion pill mifepristone, after an appeals court suspended deliveriesSTAT · 2mo ago↗ source
- Federal court blocks mailing of mifepristoneLongevity "blue zones," an update on uterine transplant science, and more Morning Rounds health newsSTAT · 2mo ago↗ source
- STAT+: Biotech raises $42 million to run Huntington’s disease trialLatus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.STAT · 2mo ago↗ source